Dr. Michael Seawell, a board-certified interventional cardiologist at DHR Health, is helping expand access to renal denervation, a minimally invasive treatment designed for patients with difficult-to-control high blood pressure.

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

Medical professionals from across Texas gathered at DHR Health for the organization’s third annual wound care symposium. This was an event dedicated entirely to wound care for the first time, according to Dr. Noel Oliveira, Director of the Wound Care Center at DHR Hea

The Texas Department of State Health Services is reporting this year’s first case of West Nile illness in a resident of Harris County. Health officials confirmed the resident was diagnosed with West Nile virus neuroinvasive disease.